In addition to the ALK rearrangements, other fusion transcripts of the genes for ROS proto-oncogene 1 (ROS1), ret-proto-oncogene (RET) or NTRK genes have been identified in 1–2% of patients with advanced stage lung cancer. The gene discussed is ALK; the disease is lung cancer.